August 12, 2025Discover OncologyOpen Access

Integrative approach for enhanced ovarian cancer diagnosis: cytology and biomarkers

View Full Paper

Ask AI

Bookmark

Authors

SCShuangyan Chen LCLei CaiUniversity of Kentucky DZDaoyin ZhouChanghai Hospital

Discussion

Member takes

Implication

Study evaluates cytology and biomarkers CA125 and CA153 in detecting malignant cells in ovarian cancer, suggesting improved diagnostic accuracy with combined testing.

Key Points

Routine cytology effectively detects malignant cells in ovarian cancer serous effusions, showing a positivity rate of 72.17%.
Combined testing of CA125 and CA153 improved sensitivity to 96.30%, highlighting its diagnostic value.
Evaluation revealed that CA125 has high sensitivity at 93.51%, significantly above CA153's 64.35%.
Results indicate that liquid-based cytology does not provide additional benefits in diagnosing malignant cells versus routine cytology.

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/68c23595b210217d6477121d https://doi.org/10.1007/s12672-025-03231-6

View Full Paper

Ask AI

Bookmark

Implication

Study evaluates cytology and biomarkers CA125 and CA153 in detecting malignant cells in ovarian cancer, suggesting improved diagnostic accuracy with combined testing.

Integrative approach for enhanced ovarian cancer diagnosis: cytology and biomarkers

Discussion

Member takes

Implication

Key Points

Cite This Study

Integrative approach for enhanced ovarian cancer diagnosis: cytology and biomarkers

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider